Viewing Study NCT00669318

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:32 AM
Ignite Modification Date: 2026-02-10 @ 11:00 AM
Study NCT ID: NCT00669318
Status: COMPLETED
Last Update Posted: 2014-07-01
First Post: 2008-04-29
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Sponsor: Mayo Clinic
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None refractory chronic lymphocytic leukemia View
None recurrent small lymphocytic lymphoma View
None B-cell chronic lymphocytic leukemia View